The glob­al top 50 bio­phar­ma com­pa­nies — End­points News style

Over the past few years, I’ve been in­trigued by the grow­ing glob­al­iza­tion of bio­phar­ma, along with the rise of new play­ers in Chi­na and around the world as some of the biggest com­pa­nies en­gage once again in ma­jor league M&A deals. Add in some big hits and miss­es on the R&D side, and there’s been a lot of changes in how the top bio­phar­ma com­pa­nies rank.

Al­so, I want­ed a list just for End­points News — one that looked sole­ly at the bio­phar­mas en­gaged in the drug de­vel­op­ment side of the busi­ness, with­out mix­ing in medtech.

To get that, I asked Sam Fazeli, the Lon­don-based an­a­lyst for Bloomberg In­tel­li­gence, to do a da­ta dump on the whole health­care field, so we could se­lect 50 unique­ly de­fined com­pa­nies for the list. In do­ing the list, he of­fered a few ob­ser­va­tions on the big changes he’s seen over the past year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.